Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples